vs

Side-by-side financial comparison of Doximity, Inc. (DOCS) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

Doximity, Inc. is the larger business by last-quarter revenue ($185.1M vs $148.5M, roughly 1.2× OPKO HEALTH, INC.). Doximity, Inc. runs the higher net margin — 33.3% vs -21.1%, a 54.3% gap on every dollar of revenue. On growth, Doximity, Inc. posted the faster year-over-year revenue change (9.8% vs -19.2%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs -7.5%).

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

DOCS vs OPK — Head-to-Head

Bigger by revenue
DOCS
DOCS
1.2× larger
DOCS
$185.1M
$148.5M
OPK
Growing faster (revenue YoY)
DOCS
DOCS
+28.9% gap
DOCS
9.8%
-19.2%
OPK
Higher net margin
DOCS
DOCS
54.3% more per $
DOCS
33.3%
-21.1%
OPK
Faster 2-yr revenue CAGR
DOCS
DOCS
Annualised
DOCS
25.2%
-7.5%
OPK

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DOCS
DOCS
OPK
OPK
Revenue
$185.1M
$148.5M
Net Profit
$61.6M
$-31.3M
Gross Margin
89.9%
43.1%
Operating Margin
38.9%
-25.8%
Net Margin
33.3%
-21.1%
Revenue YoY
9.8%
-19.2%
Net Profit YoY
-18.1%
-322.8%
EPS (diluted)
$0.31
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOCS
DOCS
OPK
OPK
Q4 25
$185.1M
$148.5M
Q3 25
$168.5M
$151.7M
Q2 25
$145.9M
$156.8M
Q1 25
$138.3M
$150.0M
Q4 24
$168.6M
$183.6M
Q3 24
$136.8M
$173.6M
Q2 24
$126.7M
$182.2M
Q1 24
$118.1M
$173.7M
Net Profit
DOCS
DOCS
OPK
OPK
Q4 25
$61.6M
$-31.3M
Q3 25
$62.1M
$21.6M
Q2 25
$53.3M
$-148.4M
Q1 25
$62.5M
$-67.6M
Q4 24
$75.2M
$14.0M
Q3 24
$44.2M
$24.9M
Q2 24
$41.4M
$-10.3M
Q1 24
$40.6M
$-81.8M
Gross Margin
DOCS
DOCS
OPK
OPK
Q4 25
89.9%
43.1%
Q3 25
90.3%
32.9%
Q2 25
89.2%
31.5%
Q1 25
89.5%
28.4%
Q4 24
91.6%
46.1%
Q3 24
90.0%
23.1%
Q2 24
89.3%
28.4%
Q1 24
89.4%
24.2%
Operating Margin
DOCS
DOCS
OPK
OPK
Q4 25
38.9%
-25.8%
Q3 25
37.8%
31.7%
Q2 25
37.4%
-38.3%
Q1 25
35.2%
-44.8%
Q4 24
47.4%
-18.0%
Q3 24
38.8%
8.2%
Q2 24
36.4%
-33.9%
Q1 24
35.5%
-41.2%
Net Margin
DOCS
DOCS
OPK
OPK
Q4 25
33.3%
-21.1%
Q3 25
36.8%
14.3%
Q2 25
36.5%
-94.7%
Q1 25
45.2%
-45.1%
Q4 24
44.6%
7.6%
Q3 24
32.3%
14.3%
Q2 24
32.7%
-5.7%
Q1 24
34.4%
-47.1%
EPS (diluted)
DOCS
DOCS
OPK
OPK
Q4 25
$0.31
$-0.04
Q3 25
$0.31
$0.03
Q2 25
$0.27
$-0.19
Q1 25
$0.31
$-0.10
Q4 24
$0.37
$0.02
Q3 24
$0.22
$0.03
Q2 24
$0.21
$-0.01
Q1 24
$0.20
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOCS
DOCS
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$64.8M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$979.3M
$1.3B
Total Assets
$1.2B
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOCS
DOCS
OPK
OPK
Q4 25
$64.8M
$364.4M
Q3 25
$169.2M
$412.0M
Q2 25
$137.3M
$267.3M
Q1 25
$209.6M
$428.8M
Q4 24
$165.3M
$426.6M
Q3 24
$184.2M
$400.1M
Q2 24
$111.4M
$40.6M
Q1 24
$96.8M
$75.6M
Total Debt
DOCS
DOCS
OPK
OPK
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
DOCS
DOCS
OPK
OPK
Q4 25
$979.3M
$1.3B
Q3 25
$1.1B
$1.3B
Q2 25
$1.0B
$1.3B
Q1 25
$1.1B
$1.3B
Q4 24
$1.0B
$1.4B
Q3 24
$961.2M
$1.4B
Q2 24
$913.6M
$1.4B
Q1 24
$901.4M
$1.3B
Total Assets
DOCS
DOCS
OPK
OPK
Q4 25
$1.2B
$1.9B
Q3 25
$1.3B
$2.0B
Q2 25
$1.2B
$2.0B
Q1 25
$1.3B
$2.1B
Q4 24
$1.2B
$2.2B
Q3 24
$1.1B
$2.3B
Q2 24
$1.1B
$2.0B
Q1 24
$1.1B
$2.0B
Debt / Equity
DOCS
DOCS
OPK
OPK
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOCS
DOCS
OPK
OPK
Operating Cash FlowLast quarter
$60.9M
$-25.9M
Free Cash FlowOCF − Capex
$-28.6M
FCF MarginFCF / Revenue
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOCS
DOCS
OPK
OPK
Q4 25
$60.9M
$-25.9M
Q3 25
$93.9M
$-34.6M
Q2 25
$62.1M
$-83.4M
Q1 25
$98.5M
$-34.6M
Q4 24
$65.2M
$-44.4M
Q3 24
$68.3M
$-77.1M
Q2 24
$41.2M
$-26.4M
Q1 24
$63.9M
$-35.6M
Free Cash Flow
DOCS
DOCS
OPK
OPK
Q4 25
$-28.6M
Q3 25
$-37.8M
Q2 25
$-86.7M
Q1 25
$-37.7M
Q4 24
$-49.8M
Q3 24
$-85.0M
Q2 24
$-33.7M
Q1 24
$-40.0M
FCF Margin
DOCS
DOCS
OPK
OPK
Q4 25
-19.3%
Q3 25
-24.9%
Q2 25
-55.3%
Q1 25
-25.2%
Q4 24
-27.1%
Q3 24
-49.0%
Q2 24
-18.5%
Q1 24
-23.0%
Capex Intensity
DOCS
DOCS
OPK
OPK
Q4 25
1.8%
Q3 25
2.1%
Q2 25
2.1%
Q1 25
0.0%
2.1%
Q4 24
0.0%
2.9%
Q3 24
0.0%
4.6%
Q2 24
0.0%
4.0%
Q1 24
0.0%
2.6%
Cash Conversion
DOCS
DOCS
OPK
OPK
Q4 25
0.99×
Q3 25
1.51×
-1.60×
Q2 25
1.16×
Q1 25
1.58×
Q4 24
0.87×
-3.17×
Q3 24
1.55×
-3.10×
Q2 24
1.00×
Q1 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons